Combined Use of Contact Aspiration and the Stent Retriever Technique Versus Stent Retriever Alone for Recanalisation in Acute Cerebral Infarction

Acute Ischemic Stroke Clinical Trial

— ASTER2  

Official title:

Combined Use of Contact Aspiration and the Stent Retriever Technique Versus Stent Retriever Alone for Recanalisation in Acute Cerebral Infarction: the Randomized ASTER2 Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03290885
• Other study ID #: 2017014F
• Secondary ID: 2016-A01735-46
• Status: Completed
• Phase: N/A
• Start date: October 16, 2017
• Est. completion date: February 28, 2020

Study information

• Verified date: May 2020
• Source: Hopital Foch
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Mechanical thrombectomy (MT) with a stent retriever (SR) device is now the standard intervention in ischemic stroke with large vessel occlusion. Favorable outcome is strongly associated with the successful reperfusion status. New device of MT such as contact aspiration seems promising to increase reperfusion status and clinical outcome.

The main hypothesis is to show the superiority of combining the use of contact aspiration with a stent retriever compared to a stent retriever alone in treatment of acute stroke due to proximal arterial occlusion.

The primary endpoint is the rate of perfect reperfusion score at the end of the endovascular procedure.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 408
• Est. completion date: February 28, 2020
• Est. primary completion date: February 28, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age 18 and older (i.e., candidates must have had their 18th birthday)

• Groin puncture carried out within 8 hours of first symptoms

• Neuroimaging demonstrates large vessel proximal occlusion (distal ICA through MCA bifurcation, M1 or M2)

• Consenting requirements met according to French laws.

• With or without intravenous thrombolysis

Exclusion Criteria:

• Absence of large vessel occlusion on non-invasive imaging

• Known or suspected pre-existing (chronic) large vessel occlusion in the symptomatic territory

• Suspected pregnancy; if, a woman is of childbearing potential, a urine or serum beta human chorionic gonadotropin (betaHCG) test is positive.

• Severe contrast medium allergy or absolute contraindication to iodinated agents.

• Patient has severe or fatal comorbidities that will likely prevent improvement or follow-up or that will render the procedure unlikely to benefit the patient.

• Acute ischemic stroke involving posterior circulation (vertebrobasilar occlusion)

• Angiographic evidence of carotid dissection or tandem cervical occlusion or stenosis requiring treatment.

• Patients benefiting from a legal protection

• Non-membership of a national insurance scheme

• Opposition of the patient or (in case of inclusion as a matter of urgency) of the trustworthy person

Related Conditions & MeSH terms

• Acute Ischemic Stroke
• Cerebral Infarction
• Infarction

Intervention

Combination Product:
• Combined contact aspiration/Stent Retriever Technique
Combined contact aspiration/SR is performed using a balloon-guide catheter (BGC). A 0.021 to 0.027 inch inner lumen microcatheter with a 0.014 to 0.016 inch micro-wire inside is introduced into a large-bore aspiration catheter and this construct is introduced into BGC. The BGC is placed into the origin of the cervical internal carotid artery (ICA). The catheter is advanced past the thrombus over the micro-wire to allow the SR deployment. The SR is deployed across the occlusion. Then the large bore distal access catheter is advanced to contact the proximal edge of the SR. The aspiration pump is connected to the large bore distal access catheter. After at least 90 sec, the SR and the large bore distal access catheter are pulled out as an unit from the BGC and the patient. Manual aspiration is also be applied to the BGC during the pull-out manoeuver which is performed after the temporary inflation of the balloon at the tip of the BGC to ensure flow arrest into the carotid

Device:
• Stent retriever technique
The technique used should be in accordance with the device instruction for use. A large bore balloon guide catheter has to be placed into the cervical ICA. A suitable delivery microcatheter is navigated over a micro-wire into the occluded major coronary artery MCA and across the occlusion. A control superselective angiogram may be used to document the extent of occlusion and thrombus. The stent retriever device is then deployed across the occlusion. After at least 90 seconds, removal should occur with proximal occlusion by inflation of the balloon guide catheter.

Locations

Country	Name	City	State
France	CHU Bordeaux	Bordeaux
France	CHU Limoges	Limoges
France	CHU Montpellier	Montpellier
France	CHU Nancy	Nancy
France	CHU Nantes	Nantes
France	Fondation Ophtalmologique Rotschild	Paris
France	Kremlin-Bicêtre (APHP)	Paris
France	La Pitié-Salpétrière (APHP)	Paris
France	Lariboisière (APHP)	Paris
France	CHU Rennes	Rennes
France	Hôpital Foch	Suresnes

Sponsors (1)

Lead Sponsor	Collaborator
Hopital Foch

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Perfect reperfusion rate	Perfect reperfusion rate at the end of angiography defined as a Thrombolysis In Cerebral Infarction (TICI) 2c/3 score (TICI score = Thrombolysis In Cerebral Infarction)	24 hours
Secondary	Rate of successful reperfusion	Rate of successful reperfusion (mTICI 2b/2c/3), and complete reperfusion (mTICI3) at end of endovascular procedure	24 hours
Secondary	Rate of perfect (mTICI 2c/3), successful reperfusion (mTICI 2b/2c/3), and complete reperfusion (mTICI3) after the frontline strategy		24 hours
Secondary	Time from groin puncture to achieve TICI 2c or better revascularization	Time from groin puncture to achieve TICI 2c or better revascularization	24 hours
Secondary	Time between groin puncture to clot contact and clot contact to maximum reperfusion	Time between groin puncture to clot contact and clot contact to maximum reperfusion	24 hours
Secondary	Modified Rankin scale (mRs)	Global disability assessed by overall distribution of mRs at 90-days	90 days
Secondary	Rate of favorable functional independence	Rate of favorable functional independence defined as a mRS 0-2 at 90 days	90 days
Secondary	Rate of excellent functional outcome	Rate of excellent functional outcome defined as a Modified Rankin scale (mRS) 0-1 at 90 days	90 days
Secondary	NIHSS score	Change in NIHSS from baseline to 24 hours (delta NIHSS)	24 hours
Secondary	Rate of symptomatic and asymptomatic intracerebral hemorrhage	Rate of symptomatic and asymptomatic intracerebral hemorrhage at MRI 24h after thrombectomy (according the third European Cooperative Acute Stroke Study (ECASS3) classification) (independent core lab adjudication).	24 hours
Secondary	Rate of parenchymal hematoma		90 days
Secondary	Rate of all-cause mortality		90 days
Secondary	Rate of periprocedural complications	- Rate of periprocedural complications: Occurrence of emboli to new territory (ENT), vasospasm, dissection, or perforation.	90 days
Secondary	Average cost per patient	Average cost per patient with complete recanalization	90 days